Aplastic Anemia

As per available reports about 413 journals and about 150707 articles are being published on the subject Aplastic Anemia. In terms of research annually, USA, India, Japan, UK, Ireland and Kenya are some of the leading countries where maximum studies related to Aplastic Anemia are being carried out.  Aplastic anemia is a disorder in which the bone marrow and blood stem cells are damaged. This type of anemia leads to deficiency of RBC, WBC and blood platelets. The RBC, WBC and Platelets are useful for the proper functioning of a body. The hemoglobin in RBC carries oxygen, WBC fights against infections causing organisms and platelets help in clotting the blood. Aplastic anemia results in malfunctioning of all the three major blood cells resulting in higher risks of infections and uncontrolled bleeding.

The Journal of Blood Disorders & Transfusion  is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Aplastic Anemia. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Blood Disorders & Transfusion provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Aplastic Anemia, thus bridging the gap between researchers and young scientists.

OMICS Group, the world pioneer for organizing 150 International conferences in USA, Europe, Asia and other continents. Uniquely, 350 peer-reviewed open access journals were operating by OMICS International. This will reflect the scope in current research and development in science, healthcare and technology. With a strong intention to accelerate the scientific discovery, OMICS Group International has been associated with more than150 scientific Societies and Associations.